Skip to search boxSkip to navigationSkip to main content

Disruption of Neurexin 1 Associated with Autism Spectrum Disorder

  • Hyung Goo Kim
    ,
  • Shotaro Kishikawa
    ,
  • Anne W. Higgins
    ,
  • Ihn Sik Seong
    ,
  • Diana J. Donovan
    ,
  • Yiping Shen
*Corresponding author for this work
  • Massachusetts General Hospital
    ,
  • Brigham and Women’s Hospital
    ,
  • Massachusetts Institute of Technology
    ,
  • Center for Human Genetic Research
    ,
  • University Medical Center Hamburg-Eppendorf
    ,
  • University of Alabama at Birmingham
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Autism is a neurodevelopmental disorder of complex etiology in which genetic factors play a major role. We have implicated the neurexin 1 (NRXN1) gene in two independent subjects who display an autism spectrum disorder (ASD) in association with a balanced chromosomal abnormality involving 2p16.3. In the first, with karyotype 46,XX,ins(16;2)(q22.1;p16.1p16.3)pat, NRXN1 is directly disrupted within intron 5. Importantly, the father possesses the same chromosomal abnormality in the absence of ASD, indicating that the interruption of α-NRXN1 is not fully penetrant and must interact with other factors to produce ASD. The breakpoint in the second subject, with 46,XY,t(1;2)(q31.3;p16.3)dn, occurs ∼750 kb 5′ to NRXN1 within a 2.6 Mb genomic segment that harbors no currently annotated genes. A scan of the NRXN1 coding sequence in a cohort of ASD subjects, relative to non-ASD controls, revealed that amino acid alterations in neurexin 1 are not present at high frequency in ASD. However, a number of rare sequence variants in the coding region, including two missense changes in conserved residues of the α-neurexin 1 leader sequence and of an epidermal growth factor (EGF)-like domain, respectively, suggest that even subtle changes in NRXN1 might contribute to susceptibility to ASD.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 199-207 (9 pages)

Journal (Volume, Issue Number)

American journal of human genetics (Volume 82, Issue 1)

Publication milestones

  • Published - 01/10/2008

Publication status

Published - 01/10/2008

ISSN

0002-9297

Publication IDs

  • Scopus: 38749084216
  • PubMed: 18179900

Publication metrics

Metrics

Fractional count
1
Fractional count
0.04
Fractional count
25
Fractional count
0.96
Fractional count
1
Fractional count
1
SciVal
citations
432
SciVal
FWCI
12.36
SciVal
Author count
26
SciVal
Paper percentile
99
SciVal
Top percentile
1
Scopus
citations

PlumX, opens in new tab

Captures
504
Social media
4
Mentions
4
Citation count
494

Funding Details

We are grateful to the DGAP families and members of the ASD, TS and OCD cohorts for their cooperation and participation in this study. We also gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. We thank Heather Ferguson, Chantal Kelly, and Jill Platko for assistance in obtaining subject samples and phenotypic data, Robert Eisenman for technical support and the CHGR Tissue Culture and Genomics Resources for lymphoblast transformation and DNA sequencing services. This work was supported by National Institutes of Health grants P01-GM061354 (to C.C.M.), U19-HD35482 (to F.V., A.K., and D.L.P), P01-HD00300838 (to F.V., A.K., and D.L.P), and R01-NS16648 (D.L.P.) and by a NARSAD Distinguished Investigator Award (J.F.G.). Y.S. received a Young Investigator Award from the Children's Tumor Foundation. AGRE is a program of Cure Autism Now and is supported, in part, by grant MH64547 from the National Institute of Mental Health to Daniel H. Geschwind (PI).
FundersFunding numbers
NIH
U19-HD35482, P01-HD00300838, P01-GM061354, R01-NS16648
NIMH
R01MH064547
NARSAD
-